Spectranetics (Nasdaq: SPNC) reported earnings on April 23. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Spectranetics beat expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share. GAAP earnings per share.

Margins shrank across the board.

Revenue details
 Spectranetics reported revenue of $37.7 million. The five analysts polled by S&P Capital IQ predicted revenue of $36.6 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $33.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.01. The five earnings estimates compiled by S&P Capital IQ predicted -$0.03 per share. Non-GAAP EPS were -$0.01 for Q1 compared to $0.00 per share for the prior-year quarter. GAAP EPS were -$0.03 for Q1 versus $0.00 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 71.2%, 180 basis points worse than the prior-year quarter. Operating margin was -4.0%, 380 basis points worse than the prior-year quarter. Net margin was -2.5%, 250 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $38.8 million. On the bottom line, the average EPS estimate is -$0.01.

Next year's average estimate for revenue is $154.8 million. The average EPS estimate is $0.02.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 156 members out of 174 rating the stock outperform, and 18 members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give Spectranetics a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Spectranetics is buy, with an average price target of $19.90.

Looking for alternatives to Spectranetics? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.